Acrobiosystems (SHE:301080) will invest 150 million yuan as a limited partner in a new venture capital fund, according to a Thursday filing with the Shenzhen bourse.
The amount is equivalent to 30% of the 500-million-yuan Suzhou Su-High-Tech Rongsheng ACRO Venture Capital Partnership.
The fund will have a duration of eight years. It will invest in upstream life science tools and services, biopharmaceuticals, medical devices, and biomanufacturing, the filing said.
The biopharmaceutical company's shares fell 9% during the afternoon session on Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments